Leiomyosarcoma
📧 Sign up to get email alerts when something new happens for Leiomyosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) [Phase 1, Phase 2]
Phase 1/2 trial of gemcitabine and docetaxel with pazopanib for neoadjuvant treatment in soft tissue sarcoma was terminated; results posted …
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma [Phase 3]
A Phase 3 trial compared trabectedin to dacarbazine in patients with advanced liposarcoma or leiomyosarcoma; results were posted in January …
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes [Phase 2]
A Phase 2 trial evaluated the combination of gemcitabine, docetaxel, and bevacizumab in selected sarcoma subtypes, including leiomyosarcoma …
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Sorafenib and Dacarbazine in Soft Tissue Sarcoma [Phase 2]
A Phase 2 study evaluating the combination of sorafenib and dacarbazine in soft tissue sarcoma reported completed results in 2015, including…
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
A Phase 2 trial evaluating saracatinib (AZD0530) in adults with recurrent, locally advanced, or metastatic soft tissue sarcoma has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED) [Phase 2]
This update reports the completion of a Phase 2 trial of ridaforolimus (AP23573/MK-8669), an mTOR inhibitor, in patients with advanced sarco…
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas [Phase 1]
Phase 1 trial evaluating the combination of gemcitabine and trabectedin in leiomyosarcoma and liposarcoma has completed. The study explored …
-
CLINICAL_TRIALS trial_result · 2014-12-01Clinical Trial Update: Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma [Phase 2]
Phase 2 adjuvant chemotherapy trial for high-risk uterine leiomyosarcoma has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung [Phase 2]
Phase 2 study evaluating REOLYSIN (pelareorep) for bone and soft tissue sarcomas metastatic to the lung has been completed, assessing safety…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer [Phase 2]
This Phase 2 trial evaluated two dosing schedules of trabectedin in patients with advanced liposarcoma or leiomyosarcoma; the study has comp…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma [Phase 2]
Phase 2 clinical trial evaluating sorafenib for metastatic, locally advanced, or recurrent sarcoma has completed and posted results in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma [Phase 2]
A Phase 2 trial evaluating temozolomide with thalidomide in patients with metastatic, locally advanced, or unresectable leiomyosarcoma.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: S9624 Ifosfamide in Treating Patients With Meningeal Tumors [Phase 2]
Phase 2 SWOG trial of ifosfamide for meningeal tumors and related sarcomas was terminated.
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating the combination of gemcitabine, docetaxel, and filgrastim in patients with recurrent or persistent leiomyosarcoma o…
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma [Phase 2]
Phase II trial results for sunitinib malate in metastatic or surgically unresectable soft tissue sarcoma were posted, evaluating activity ac…
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Safety and Efficacy Study of ARQ 501 in Adult Patients With Leiomyosarcoma [Phase 2]
Phase 2 safety and efficacy results for ARQ 501 in adults with leiomyosarcoma; the study has been completed.